• Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.
    • Groelly FJ, Porru M, Zimmer J, Benainous H, De Visser Y, Kosova AA, Di Vito S, Serra V, Ryan A, Leonetti C, Bruna A, Biroccio A, Tarsounas M.
    • EMBO Mol Med. 2022 Feb 2:e14501. doi: 10.15252/emmm.202114501. Epub ahead of print.